Biosynex SA (EPA: ALBIO)

Market Cap	13.95M
Revenue (ttm)	104.07M
Net Income (ttm)	-38.48M
Shares Out	10.76M
EPS (ttm)	-3.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,697
Open	1.300
Previous Close	1.350
Day's Range	1.290 - 1.350
52-Week Range	1.280 - 8.970
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 25, 2025

About Biosynex

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 569
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALBIO